Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study
Overview of attention for article published in Lancet Oncology, January 2022
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (97th percentile)
-
High Attention Score compared to outputs of the same age and source (82nd percentile)
Mentioned by
- news
- 7 news outlets
- blogs
- 1 blog
- 27 X users
- patent
- 2 patents
- guideline
- 3 clinical guideline sources
- podcasts
- 1 podcast
Readers on
- mendeley
- 109 Mendeley